These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11281470)

  • 1. Exploration of cyclical changes in memory and mood in postmenopausal women taking sequential combined oestrogen and progestogen preparations.
    Natale V; Albertazzi P; Zini M; Di Micco R
    BJOG; 2001 Mar; 108(3):286-90. PubMed ID: 11281470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of tibolone versus continuous combined norethisterone acetate and oestradiol on memory, libido and mood of postmenopausal women: a pilot study.
    Albertazzi P; Natale V; Barbolini C; Teglio L; Di Micco R
    Maturitas; 2000 Oct; 36(3):223-9. PubMed ID: 11063905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
    Lethaby A; Farquhar C; Sarkis A; Roberts H; Jepson R; Barlow D
    Cochrane Database Syst Rev; 2000; (2):CD000402. PubMed ID: 10796715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of sublingual and topical compounded bioidentical hormone replacement therapy in postmenopausal women: an observational cohort study.
    Ruiz AD; Daniels KR
    Int J Pharm Compd; 2014; 18(1):70-7. PubMed ID: 24881343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous transdermal oestrogen and interrupted progestogen as a novel bleed-free regimen of hormone replacement therapy for postmenopausal women.
    Cameron ST; Critchley HO; Glasier AF; Williams AR; Baird DT
    Br J Obstet Gynaecol; 1997 Oct; 104(10):1184-90. PubMed ID: 9332998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy.
    Sturdee DW; Ulrich LG; Barlow DH; Wells M; Campbell MJ; Vessey MP; Nielsen B; Anderson MC; Bragg AJ
    BJOG; 2000 Nov; 107(11):1392-400. PubMed ID: 11117768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of tibolone on mood and libido.
    Davis SR
    Menopause; 2002; 9(3):162-70. PubMed ID: 11973439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal dose combined hormonal replacement therapy for menopausal women.
    Wren BG
    Med J Aust; 1981 Apr; 1(7):353-6. PubMed ID: 7242418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised comparison of oestrogen versus oestrogen plus progestogen hormone replacement therapy in women with hysterectomy. Medical Research Council's General Practice Research Framework.
    BMJ; 1996 Feb; 312(7029):473-8. PubMed ID: 8597678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
    Norman RJ; Flight IH; Rees MC
    Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oestrogen-only and oestrogen-progestogen replacement therapy upon circulating angiotensin I-converting enzyme activity in postmenopausal women.
    Proudler AJ; Cooper A; Whitehead M; Stevenson JC
    Clin Endocrinol (Oxf); 2003 Jan; 58(1):30-5. PubMed ID: 12519409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal and non-hormonal interventions for menopausal symptoms.
    Coope J
    Maturitas; 1996 Mar; 23(2):159-68. PubMed ID: 8735354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
    Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the addition of methyltestosterone to combined hormone therapy with estrogens and progestogens on sexual energy and on orgasm in postmenopausal women.
    Penteado SR; Fonseca AM; Bagnoli VR; Abdo CH; Júnior JM; Baracat EC
    Climacteric; 2008 Feb; 11(1):17-25. PubMed ID: 18202961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous versus cyclical transdermal estrogen replacement therapy in postmenopausal women: influence on climacteric symptoms, body weight and bleeding pattern.
    Lübbert H; Nauert C
    Maturitas; 1997 Dec; 28(2):117-25. PubMed ID: 9522319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of symptoms in relation to androgen concentrations in women using estrogen plus progestogen and women using estrogen alone.
    Spetz AC; Fredriksson MG; Lidfeldt J; Samsioe GN
    Menopause; 2009; 16(1):149-55. PubMed ID: 18779755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of nomegestrol acetate on the improvement of the quality of life induced by estrogen therapy in menopausal women].
    Reginster JY; Zartarian M; Colau JC
    Contracept Fertil Sex; 1996 Nov; 24(11):847-51. PubMed ID: 8991589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of methyl testosterone administration on plasma viscosity in postmenopausal women.
    Basaria S; Nguyen T; Rosenson RS; Dobs AS
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):209-14. PubMed ID: 12153599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term hormone therapy for perimenopausal and postmenopausal women.
    Marjoribanks J; Farquhar C; Roberts H; Lethaby A
    Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial factors under treatment with oestrogen and oestrogen/progestogen combinations.
    Aylward M; Maddock J; Parker A; Protheroe DA; Ward A
    Postgrad Med J; 1978; 54 Suppl 2():74-81. PubMed ID: 740584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.